{"id":"W2017006015","doi":"10.1182/blood-2012-03-413112","title":"CyBorD: stellar response rates in AL amyloidosis","year":2012,"lang":"en","type":"letter","venue":"Blood","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"AL amyloidosis; Bortezomib; Dexamethasone; Cyclophosphamide; Medicine; Internal medicine; Amyloidosis; Gastroenterology; Multiple myeloma; Immunology; Chemotherapy; Immunoglobulin light chain","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003996126,0.0006747538,0.0006058433,0.000231292,0.00007345669,0.00005617531,0.0005359047,0.001427973,0.0001632498],"category_scores_gemma":[0.0002413034,0.0006467783,0.0003416291,0.0001836488,0.00009778683,0.000006929477,0.0002775212,0.0007369239,0.0002464869],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006019908,"about_ca_system_score_gemma":0.0001661165,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007795693,"about_ca_topic_score_gemma":0.00004203733,"domain_scores_codex":[0.9968749,0.0005248357,0.0005060205,0.0008760069,0.0003262121,0.0008920705],"domain_scores_gemma":[0.9982688,0.0001927857,0.0002537525,0.001095401,0.00006683597,0.0001223694],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002527247,0.0006656823,0.121886,0.00006503366,0.0006267623,0.0003608299,0.00006510542,0.000001694953,0.03401817,0.000001530817,0.8417855,0.0002709546],"study_design_scores_gemma":[0.00220517,0.0002931224,0.01553742,0.00005896306,0.0003112204,0.00004563538,0.00002534676,3.125486e-7,0.1349529,0.0000062283,0.8458866,0.0006770781],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.7996698,0.01149094,0.000007598177,0.1862517,0.0005853417,0.0007893792,0.0003443703,0.00006119431,0.00079968],"genre_scores_gemma":[0.357766,0.003851351,0.0008337342,0.6215193,0.00448794,0.0007247369,0.00292078,0.000418499,0.007477607],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.4419038,"threshold_uncertainty_score":0.9998684,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01250620776437253,"score_gpt":0.2652144677778667,"score_spread":0.2527082600134941,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}